77 filings
10-Q
2024 Q1
PRME
Prime Medicine Inc
Quarterly report
10 May 24
8:22am
8-K
PRME
Prime Medicine Inc
10 May 24
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
8:05am
ARS
2023 FY
PRME
Prime Medicine Inc
29 Apr 24
Annual report to shareholders
4:08pm
DEFA14A
PRME
Prime Medicine Inc
29 Apr 24
Additional proxy soliciting materials
4:05pm
DEF 14A
PRME
Prime Medicine Inc
Definitive proxy
29 Apr 24
4:03pm
PRE 14A
ebnqh
19 Apr 24
Preliminary proxy
4:07pm
S-8
7jt5ol8n 73j
1 Mar 24
Registration of securities for employees
8:09am
8-K
7y9jm lglubvv
1 Mar 24
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
8:01am
8-K
b5jwog02bu
16 Feb 24
Entry into a Material Definitive Agreement
6:23am
424B5
cji bzk8z5dv9kee1pq
16 Feb 24
Prospectus supplement for primary offering
6:17am
FWP
j8yodc
14 Feb 24
Free writing prospectus
9:57pm
424B5
rb37h 0akbszw185
14 Feb 24
Prospectus supplement for primary offering
5:27pm
8-K
yo96di8 3bmuyto6mb
14 Feb 24
Results of Operations and Financial Condition
4:12pm
8-K
3zogmjwnefa2tgy
8 Jan 24
Regulation FD Disclosure
8:01am
8-K
8vo8kpy553m
5 Jan 24
Other Events
5:03pm
8-K
3yddp32gnl qv6k2fo
5 Jan 24
Departure of Directors or Certain Officers
8:15am
EFFECT
st93dxm 1m1
14 Nov 23
Notice of effectiveness
12:15am
CORRESP
8ucvb cf6j3dsoxxqdh
9 Nov 23
Correspondence with SEC
12:00am
UPLOAD
wczcmbd2
7 Nov 23
Letter from SEC
12:00am